Professors in Leuven have collaborated in the development of a new test which makes it quicker and cheaper to genetically diagnose blood disorders, heralding a significant step forward in the treatmen
The test that can be used for early detection of the Ebola virus, developed by the Mechelen-based biotechnology company Biocartis, has just received the green light from the U.S.
Belgian scientists at the universities of Copenhagen and Liege have developed a new method that can quickly predict whether patients will recover from a coma.